Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival

Following surgery for oesophageal cancer, positive circumferential resection margin (CRM) (R1), defined as margin <1mm, is an associated predictor of poor survival. The role of selective adjuvant radiotherapy in patients with R1 margin following neo-adjuvant chemotherapy (NACT) is unclear. We...

Detaylı Bibliyografya
Asıl Yazarlar:	Teoh, S, Virdee, PS, Mason, J, Patel, K, Warner, N, Hobbs, C, Sabbagh, A, Marshall, RE, Maynard, ND, Sgromo, B, Gillies, RS, Streets, CG, Barham, CP, Hollowood, AD, Titcomb, DR, Blazeby, JM, Falk, S, Mukherjee, S
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	National Cancer Research Institute 2018

Benzer Materyaller

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
Yazar:: Teoh, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Yazar:: Findlay, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Yazar:: John M. Findlay, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

Oesophageal perforation during neo-adjuvant brachytherapy for oesophageal squamous cell carcinoma
Yazar:: Maryam H. Esfehani, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
Yazar:: Reynolds John, ve diğerleri
Baskı/Yayın Bilgisi: (2007-08-01)

Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Yazar:: Thi N. Q. Nguyen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
Yazar:: den Boer, RB, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
Yazar:: Kieran G. Foley, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study
Yazar:: L. Alexandre, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

What is the optimal neo-adjuvant treatment for liver metastasis?
Yazar:: Sigurdis Haraldsdottir, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

P001 Scalp cooling system for breast cancer patients treated by adjuvant or neo-adjuvant chemotherapy
Yazar:: M. Hosoda, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Yazar:: Astrid E. Slagter, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
Yazar:: Rana, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Adjuvant and neo‐adjuvant immunotherapy in resectable non‐small cell lung cancer (NSCLC): Current status and perspectives
Yazar:: Ziyi Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

The Impact of Neo-adjuvant and Adjuvant Chemotherapy in Treatment Outcome of Patients with High Risk Soft Tissue Sarcomas of the Extremities
Yazar:: Rasha Hamdy Hamed, ve diğerleri
Baskı/Yayın Bilgisi: (2012-04-01)

The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
Yazar:: Pooya Dibajnia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
Yazar:: Sinead Cremen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Yazar:: Dodaro Concetta Anna, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

Evaluation of neo-adjuvant, concurrent and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma: a meta-analysis.
Yazar:: Fahimeh Akhlaghi, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

The use of neo - adjuvant denosumab in treatment of giant cell tumours of the spine
Yazar:: Beresford-Cleary, N, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

The Successful Use of Neo Adjuvant Brentuximab Vedotin in the Treatment of BIA-ALCL
Yazar:: Rebecca L. Allchin, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Life quality indexes in neo-adjuvant chemotherapy in laryngopharynx cancer patients
Yazar:: N. V. Grin
Baskı/Yayın Bilgisi: (2019-09-01)

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
Yazar:: Kai R. Plunkett, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
Yazar:: Reva K. Basho, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Yazar:: Song Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2012-11-01)

Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
Yazar:: Nadia Bianco, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Morphological Estimation of Cellularity on Neo-Adjuvant Treated Breast Cancer Histological Images
Yazar:: Mauricio Alberto Ortega-Ruiz, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
Yazar:: Gwen Schroyen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
Yazar:: Chaitanyanand B. Koppiker, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Study of Tumour Cellularity in Locally Advanced Breast Carcinoma on Neo-Adjuvant Chemotherapy
Yazar:: Swarup Kumar, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Yazar:: G S Bhattacharyya, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Review: Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers
Yazar:: D.G. Power, ve diğerleri
Baskı/Yayın Bilgisi: (2009-11-01)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
Yazar:: Yan Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Yazar:: Chengli Du, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
Yazar:: Maen Abdelrahim, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

SA 11.1 Post-menopausal: Who needs chemotherapy in the neo (adjuvant) setting?
Yazar:: S. Loibl
Baskı/Yayın Bilgisi: (2023-03-01)

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients
Yazar:: K. K. Laktionov, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
Yazar:: Luigi Rossi, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01)

Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer
Yazar:: Benedikt eEngels, ve diğerleri
Baskı/Yayın Bilgisi: (2012-05-01)

PATHOLOGICAL ASSESSMENTOF TUMOR RESPONSE IN A NEO-ADJUVANT THERAPY TREATED RESECTIONS FOR OSTEOSARCOMAS
Yazar:: Syed Gardezi Saad Gardezi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)